Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems

References

• Akimoto T, Aoyagi T, Minoshima J, Nagase Y. (1997). Polymeric percutaneous drug penetration enhancer: synthesis and enhancing property of PEG/PDMS block copolymer with a cationic end group. J Control Release 49:229–41
   Web of Science ®Google Scholar
• Akimoto T, Kawahara K, Nagase Y, Aoyagi T. (2000). Preparation of oligodimethylsiloxanes with sugar moiety at a terminal group as a transdermal penetration enhancer. Macromol Chem Phys 201:2729–34
   Web of Science ®Google Scholar
• Akimoto T, Kawahara K, Nagase Y, Aoyagi T. (2001). Polymeric transdermal drug penetration enhancer: the enhancing effect of oligodimethylsiloxane containing a glucopyranosyl end group. J Control Release 77:49–57
   PubMed Web of Science ®Google Scholar
• Akimoto T, Nagase Y. (2003). Novel transdermal drug penetration enhancer: synthesis and enhancing effect of alkyldisiloxane compounds containing glucopyranosyl group. J Control Release 88:243–52
   PubMed Web of Science ®Google Scholar
• Aoyagi T, Akimoto T, Nagase Y. (1992a). Novel silicones for transdermal therapeutic system, IV. Modified route to prepare oligodimethylsiloxane containing cationic end-group and its property as transdermal penetration enhancer. Makromo Chem 193:2821–8
   Web of Science ®Google Scholar
• Aoyagi T, Nakamura T, Yabuchi Y, Nagase Y. (1992b). Novel silicones for transdermal therapeutic system III: Preparation of pyridinio or ammonio-terminated polydimethylsiloxanes and the evaluation as transdermal penetration enhancer. Polymer 24:545–53
   Web of Science ®Google Scholar
• Aoyagi T, Tadenuma R, Nagase Y. (1996). Novel silicones for transdermal therapeutic system, 6. Preparation of oligodimethylsiloxane containing 2-pyrrolidone moiety as a terminal group and its enhancing effect on transdermal drug penetration. Macromol Chem Phys 197:677–86
   Web of Science ®Google Scholar
• Aoyagi T, Takamura K, Nagase Y. (1992c). Novel silicones for transdermal therapeutic system. II. Preparation of oligodimethylsiloxanes containing diethyl phosphoramidate group at the chain end and the the evaluation as transdermal penetration enhancer. Polymer J 24:375–81
   Web of Science ®Google Scholar
• Aoyagi T, Takamura Y, Nakamura T, et al. (1992d). Novel silicones for transdermal therapeutic systems: 1. Synthesis of 1-methyl-4-pyridinio-terminated polydimethylsiloxane and evaluation as a transdermal penetration enhancer. Polymer 33:2203–7
   Web of Science ®Google Scholar
• Aoyagi T, Terashima O, Nagase Y, Matsui K. (1991). Preparation of a polymer containing hexadecylpyridinium bromide groups and its utilization as a transdermal drug penetration enhancer. Polymer 32:2106–11
   Web of Science ®Google Scholar
• Aoyagi T, Terashima O, Suzuki N, et al. (1990). Polymerization of benzalkonium chloride-type monomer and application to percutaneous drug absorption enhancer. J Control Release 13:63–71
   Web of Science ®Google Scholar
• Arima H, Miyaji T, Irie T, et al. (1996). Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment. Chem Pharm Bull 44:582–6
   PubMed Web of Science ®Google Scholar
• Babita K, Rana V, Tiwary AK. (2005). Lipid synthesis inhibitors: effect on epidermal lipid conformational changes and percutaneous permeation of levodopa. AAPS PharmSciTech 6:E473–81
   PubMed Web of Science ®Google Scholar
• Babita K, Tiwary AK. (2004a). Skin lipid synthesis inhibition: a possible means for enhancing percutaneous delivery of levodopa. Curr Drug Deliv 1:397–403
   PubMedGoogle Scholar
• Babita K, Tiwary AK. (2004b). Transcutaneous delivery of levodopa: enhancement by fatty acid synthesis inhibition. Mol Pharm 2:57–63
   Google Scholar
• Babita SG, Tiwary AK. (2002). Role of sphingosine synthesis inhibition in transcutaneous delivery of levodopa. Int J Pharm 238:43–50
   PubMedGoogle Scholar
• Bason MM, Gordon V, Maibach HI. (1991). Skin Irritation. Int J Dermatol 30:623–6
   PubMed Web of Science ®Google Scholar
• Berardesca E, Distante F. (1994). The modulation of skin irritation. Contact Dermatitis 31:281–7
   PubMed Web of Science ®Google Scholar
• Borowska K, Laskowska B, Magoń A, et al. (2010). PAMAM dendrimers as solubilizers and hosts for 8-methoxypsoralene enabling transdermal diffusion of the guest. Int J Pharm 398:185–9
   PubMed Web of Science ®Google Scholar
• Borowska K, Wołowiec S, Rubaj A, et al. (2012). Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene – in vivo study. Int J Pharm 426:280–3
   PubMed Web of Science ®Google Scholar
• Bos JD, Meinardi MM. (2000). The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 9:165–9
   PubMed Web of Science ®Google Scholar
• Brown MB. (2006). Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 13:175–87
   PubMed Web of Science ®Google Scholar
• Carmichael NM, Dostrovsky JO, Charlton MP. (2010). Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin. Pain 149:316–24
   PubMed Web of Science ®Google Scholar
• Chauhan AS, Sridevi S, Chalasani KB, et al. (2003). Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J Control Release 90:335–43
   PubMed Web of Science ®Google Scholar
• Chen Y, Shen Y, Guo X, et al. (2006). Transdermal protein delivery by a coadministered peptide identified via phage display. Nat Biotechnol 24:455–60
   PubMed Web of Science ®Google Scholar
• Cheng Y, Man N, Xu T, et al. (2007). Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J Pharm Sci 96:595–602
   PubMed Web of Science ®Google Scholar
• Davaran S, Hanaee J, Rashidi MR, et al. (2006). Influence of poly (ethylene glycol)-γ-cyclodextrin complexes on stabilization and transdermal permeation of ascorbic acid. J Biomed Mater Res A 78:590–4
   PubMedGoogle Scholar
• de Jager MW, Gooris GS, Dolbnya IP, et al. (2004). Modelling the stratum corneum lipid organisation with synthetic lipid mixtures: the importance of synthetic ceramide composition. BBA-Biomembranes 1684:132–40
   Google Scholar
• Di Colo G, Burgalassi S, Zambito Y. (2004). Effects of different N-trimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation. J Pharm Sci 93:2851–62
   PubMed Web of Science ®Google Scholar
• Duncan R, Izzo L. (2005). Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215–37
   PubMed Web of Science ®Google Scholar
• Elias PM, Tsai J, Menon GK, et al. (2002). The potential of metabolic interventions to enhance transdermal drug delivery. J Investig Dermatol Symp Proc 7:79–85
   PubMed Web of Science ®Google Scholar
• Fawell S, Seery J, Daikh Y, et al. (1994). TAT-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 91:664–8
   PubMed Web of Science ®Google Scholar
• Feingold KR. (2007). Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 48:2531–46
   PubMed Web of Science ®Google Scholar
• Feingold KR. (2009). The outer frontier: the importance of lipid metabolism in the skin. J Lipid Res 50:s417–22
   PubMed Web of Science ®Google Scholar
• Filipowicz A, Wołowiec S. (2011). Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers. Int J Pharm 408:152–6
   PubMed Web of Science ®Google Scholar
• Finnin BC, Morgan TM. (1999). Transdermal penetration enhancers: applications, limitations, and potential. J Pharm Sci 88:955–8
   PubMed Web of Science ®Google Scholar
• Giuseppina S, Silvia R, Maria CB, et al. (2005). Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule. Int J Pharm 297:146–55
   PubMedGoogle Scholar
• Gonçalves E, Kitas E, Seelig J. (2005). Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide. Biochemstry 44:2692–702
   PubMed Web of Science ®Google Scholar
• Guillard EC, Tfayli A, Laugel C, Baillet-Guffroy A. (2009). Molecular interactions of penetration enhancers within ceramides organization: A FTIR approach. Eur J Pharm Sci 36:192–9
   PubMed Web of Science ®Google Scholar
• Gupta M, Mahajan A, Babita K, et al. (2004). Inhibition of skin sphingosine synthesis: enhanced percutaneous permeation of 5-fluorouracil. Pharmzie 59:212–6
   PubMed Web of Science ®Google Scholar
• Hadgraft J. (2004). Skin deep. Eur J Pharm Biopharm 58:291–9
   PubMed Web of Science ®Google Scholar
• He W, Guo X, Xiao L, Feng M. (2009). Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers. Int J Pharm 382:234–43
   PubMed Web of Science ®Google Scholar
• He W, Guo X, Zhang M. (2008). Transdermal permeation enhancement of N-trimethyl chitosan for testosterone. Int J Pharm 356:82–7
   PubMed Web of Science ®Google Scholar
• Ho A, Schwarze SR, Mermelstein SJ, et al. (2001). Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res 61:474–7
   PubMed Web of Science ®Google Scholar
• Hou YW, Chan MH, Hsu HR, et al. (2007). Transdermal delivery of proteins mediated by non-covalently associated arginine-rich intracellular delivery peptides. Exp Dermatol 16:999–1006
   PubMed Web of Science ®Google Scholar
• Hsu T, Mitragotri S. (2011). Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer. Proc Natl Acad Sci USA 108:15816–21
   PubMed Web of Science ®Google Scholar
• Jonker C, Hamman JH, Kotzé AF. (2002). Intestinal paracellular permeation enhancement with quaternized chitosan: in situ and in vitro evaluation. Int J Pharm 238:205–13
   PubMed Web of Science ®Google Scholar
• Karande P, Jain A, Ergun K, et al. (2005). Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci USA 102:4688–93
   PubMed Web of Science ®Google Scholar
• Karande P, Mitragotri S. (2009). Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophysica Acta 1788:2362–73
   PubMed Web of Science ®Google Scholar
• Kaushik S, Krishnan A, Prausnitz MR, Ludovice PJ. (2001). Magainin-mediated disruption of stratum corneum lipid vesicles. Pharm Res 18:894–6
   PubMed Web of Science ®Google Scholar
• Kim YC, Late S, Banga AK, et al. (2008). Biochemical enhancement of transdermal delivery with magainin peptide: modification of electrostatic interactions by changing pH. Int J Pharm 362:20–8
   PubMed Web of Science ®Google Scholar
• Kim YC, Ludovice PJ, Prausnitz MR. (2007). Transdermal delivery enhanced by magainin pore-forming peptide. J Control Release 122:375–83
   PubMed Web of Science ®Google Scholar
• Kotzé AF, Luessen HL, Kotzé HL, de Leeuw BJ, et al. (1997). N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surface: in vitro evaluation in intestinal epithelial cells (Caco-2). Pharm Res 14:1197–202
   PubMed Web of Science ®Google Scholar
• Küchler S, Radowski MR, Blaschke T, et al. (2009). Nanoparticles for skin penetration enhancement – a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm 71:243–50
   PubMed Web of Science ®Google Scholar
• Kumar S, Sahdev P, Perumal O, Tummala H. (2012). Identification of a novel skin penetration enhancement peptide by phage display peptide library screening. Mol Pharm 9:1320–30
   PubMed Web of Science ®Google Scholar
• Legendre JY, Rault I, Petit A, et al. (1995). Effects of β-cyclodextrins on skin: implications for the transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977. Eur J Pharm Sci 3:311–22
   Web of Science ®Google Scholar
• Li Y, Quan Y, Zang L, et al. (2009). Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules. J Pharm Pharmacol 61:1005–12
   PubMed Web of Science ®Google Scholar
• Li Y, Quan Y, Zang L, et al. (2008). Transdermal delivery of insulin using trypsin as a biochemical enhancer. Biol Pharm Bull 31:1574–9
   PubMed Web of Science ®Google Scholar
• Lim JM, Chang MY, Park SG, et al. (2003). Penetration enhancement in mouse skin and lipolysis in adipocytes by TAT-GKH, a new cosmetic ingredient. J Cosmet Sci 54:483–91
   PubMedGoogle Scholar
• Loftsson T, Masson M. (2001). Cyclodextrins in topical drug formulations: theory and practice. Int J Pharm 225:15–30
   PubMed Web of Science ®Google Scholar
• Loftsson T, Olafsson JH. (1998). Cyclodextrins: new drug delivery systems in dermatology. Int J Dermatol 37:241–6
   PubMed Web of Science ®Google Scholar
• Loftsson T, Sigurđardóttir AM, ólafsson JH. (1995). Improved acitretin delivery through hairless mouse skin by cyclodextrin complexation. Int J Pharm 115:255–8
   Web of Science ®Google Scholar
• Loftsson T, Sigurđardóttir AM. (1997). Cyclodextrins as skin penetration enhancers. In: Szejtli J, Szente L, eds. Proceedings of the eighth international symposium on cyclodextrins. Dordrecht, Netherlands: Kluwer Academic Publishers, 403–6
   Google Scholar
• Lopes L B, Brophy CM, Furnish E, et al. (2005). Comparative study of the skin penetration of protein transduction domains and a conjugated peptide. Pharm Res 22:750–7
   PubMed Web of Science ®Google Scholar
• Lopez RFV, Collett JH, Bentley MV. (2000). Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Int J Pharm 200:127–32
   PubMed Web of Science ®Google Scholar
• Lv H, Zhang Z, Wang X, et al. (2011). A biomimetic chitosan derivates: preparation, characterization and transdermal enhancement studies of N-arginine chitosan. Molecules 16:6778–90
   PubMed Web of Science ®Google Scholar
• Matsuda H, Arima H. (1999). Cyclodextrins in transdermal and rectal delivery. Adv Drug Deliver Rev 36:81–99
   PubMed Web of Science ®Google Scholar
• Matsuzaki K, Nakamura A, Murase O, et al. (1997). Modulation of magainin 2-lipid bilayer interactions by peptide charge. Biochemistry 36:2104–11
   PubMed Web of Science ®Google Scholar
• Menon GK, Ghadially R, Williams ML, Elias PM. (1992). Lamellar bodies as delivery systems of hydrolytic enzymes: implications for normal and abnormal desquamation. Br J Dermatol 126:337–45
   PubMed Web of Science ®Google Scholar
• Menon GK. (2002). New insights into skin structure: scratching the surface. Adv Drug Deliver Rev 54:S3–17
   PubMed Web of Science ®Google Scholar
• Mignani S, Kazzouli SE, Bousmina M, Majoral JP. (2013). Expand classical drug administration ways by emerging routes using dendrimers drug delivery systems: a concise overview. Adv Drug Deliv Rev http://dx.doi.org/10.1016/j.addr.2013.01.001.
   Google Scholar
• Nagase Y, Aoyagi T, Akimoto T, Fuchikami T. (1992). Novel silicones for transdermal therapeutic system, V. A novel method of preparation of carboxy-terminated polydimethylsiloxane and its enhancing effect on transdermal drug penetration. Makromol Chem 13:441–6
   Google Scholar
• Naik A, Kalia YN, Guy RH. (2000). Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technol Today 3:318–26
   PubMedGoogle Scholar
• Nanjwade BK, Bechra HM, Derkar GK, et al. (2009). Dendrimers: emerging polymers for drug-delivery systems. Eur J Pharm Sci 38:185–96
   PubMed Web of Science ®Google Scholar
• Nasrollahi SA, Taghibiglou C, Azizi E, Farboud ES. (2012). Cell-penetrating peptides as a novel transdermal drug delivery system. Chem Biol Drug Des 80:639–46
   PubMed Web of Science ®Google Scholar
• Ohtake K, Maeno T, Ueda H, et al. (2003). Poly-L-arginine predominantly increases the paracelullar permeability of hydrophilic macromolecules across rabbit nasal epithelium in vitro. Pharm Res 20:153–60
   PubMed Web of Science ®Google Scholar
• Orienti I, Zecchi V, Bertasi V, Fini A. (1991). Release of ketoprofen from dermal bases in presence of endrimersns: effect of the affinity constant determined in semisolid vehicles. Arch Pharm 324:943–7
   PubMed Web of Science ®Google Scholar
• Pathan IB, Setty CM. (2009). Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res 8:173–9
   Web of Science ®Google Scholar
• Patil S, Singh P, Szolar-Platzer C, Maibach H. (1996). Epidermal enzymes as penetration enhancers in transdermal drug delivery? J Pharm Sci 85:249–52
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Langer R. (2008). Transdermal drug delivery. Nat Biotechnol 26:1261–8
   PubMed Web of Science ®Google Scholar
• Rothbard JB, Garlington S, Lin Q, et al. (2000). Conjugation of arginine oligomers to endrimersn A facilitates topical delivery and inhibition of inflammation. Nat Med 6:1253–7
   PubMed Web of Science ®Google Scholar
• Sakuma S, Suita M, Masaoka Y, et al. (2010). Oligoarginine-linked polymers as a new class of penetration enhancers. J Control Release 148:187–96
   PubMed Web of Science ®Google Scholar
• Sapra B, Jain S, Tiwary AK. (2008). Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation. Drug Deliv 15:443–54
   PubMed Web of Science ®Google Scholar
• Schwarze SR, Dowdy SF. (2000). In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 21:45–8
   PubMed Web of Science ®Google Scholar
• Shaker DS, Ghanem AH, Li SK, et al. (2003). Mechanistic studies of the effect of hydroxypropyl-β-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin. Int J Pharm 253:1–11
   PubMed Web of Science ®Google Scholar
• Sinha VR, Kaur MP. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26:1131–40
   PubMed Web of Science ®Google Scholar
• Sinico C, Fadda AM. (2006). Vesicular carriers for dermal drug delivery. Exp Opin Drug Deliv 6:813–25
   Google Scholar
• Sun M, Fan A, Wang Z, Zhao Y. (2012). Dendrimer-mediated drug delivery to the skin. Soft Matter 8:4301–5
   Web of Science ®Google Scholar
• Tanner T, Marks R. (2008). Delivering drugs by the transdermal route: review and comment. Skin Res Technol 14:249–60
   PubMed Web of Science ®Google Scholar
• Taveira SF, Nomizo A, Lopez RFV. (2009). Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity. J Control Release 134:35–40
   PubMed Web of Science ®Google Scholar
• Thanou M, Verhoef JC, Junginger HE. (2001). Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev 50:S91–101
   PubMed Web of Science ®Google Scholar
• Thanou MM, Kotzé AF, Scharringhausen T, et al. (2000). Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers. J Control Release 64:15–25
   PubMed Web of Science ®Google Scholar
• Thomas BJ, Finnin BC. (2004). The transdermal revolution. Drug Discov Today 9:697–703
   PubMed Web of Science ®Google Scholar
• Tsai JC, Guy RH, Thornfeldt CR, et al. (1996). Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. J Pharm Sci 85:643–8
   PubMed Web of Science ®Google Scholar
• Uchida T, Kanazawa T, Takashima Y, Okada H. (2011). Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002. Chem Pharm Bull 59:196–201
   PubMed Web of Science ®Google Scholar
• Umemura M, Ueda H, Tomono K, Nagai T. (1990). Effect of diethyl-beta-cyclodextrin on the release of nitroglycerin from formulations. Drug Des Deliv 6:297–310
   PubMedGoogle Scholar
• Ventura CA, Tommasini S, Falcone A, et al. (2006). Influence of modified endrimersns on solubility and percutaneous absorption of celecoxib through human skin. Int J Pharm 314:37–45
   PubMed Web of Science ®Google Scholar
• Venuganti VV, Sahdev P, Hildreth M, et al. (2011). Structure--skin permeability relationship of dendrimers. Pharm Res 28:2246–60
   PubMed Web of Science ®Google Scholar
• Venuganti VVK, Perumal OP. (2008). Effect of poly(amidoamine) (PAMAM) endrimers on skin permeation of 5-fluorouracil. Int J Pharm 361:230–8
   PubMed Web of Science ®Google Scholar
• Venuganti VVK, Perumal OP. (2009). Poly(amidoamine) dendrimers as skin penetration enhancers: influence of charge, generation, and concentration. J Pharm Sci 98:2345–56
   PubMed Web of Science ®Google Scholar
• Vivès E. (2003). Cellular uptake of the Tat peptide: an endocytosis mechanism following ionic interactions. J Mol Recognit 16:265–71
   PubMed Web of Science ®Google Scholar
• Walker RB, Smith EW. (1996). The role of percutaneous penetration enhancers. Adv Drug Deliver Rev 18:295–301
   Web of Science ®Google Scholar
• Wang Z, Itoh Y, Hosaka Y, et al. (2003a). Novel transdermal drug delivery system with polyhydroxyalkanoate and starburst polyamidoamine endrimers. J Biosci Bioeng 95:541–3
   PubMed Web of Science ®Google Scholar
• Wang Z, Itoh Y, Hosaka Y, et al. (2003b). Mechanism of enhancement effect of endrimers on transdermal drug permeation through polyhydroxyalkanoate matrix. J Biosci Bioeng 96:537–40
   PubMed Web of Science ®Google Scholar
• Welss T, Basketter DA, Schröder KR. (2004). In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol In Vitro 18:231–43
   PubMed Web of Science ®Google Scholar
• Wertz PW, van den Beergh B. (1998). The physical, chemical and functional properties of lipids in the skin and other biological barriers. Chem Phys Lipids 91:85–96
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliver Rev 56:603–18
   PubMed Web of Science ®Google Scholar
• Yang Y, Sunoqrot S, Stowell C, et al. (2012). Effect of size, surface charge, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetration. Biomacromolecules 13:2154–62
   PubMed Web of Science ®Google Scholar
• Zaro J, Shen WC. (2003). Quantitative comparison of membrane transduction and endocytosis of oligopeptides. Biochem Biophys Res Commun 307:241–7
   PubMed Web of Science ®Google Scholar
• Zasloff M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin-isolation, characterization of two active forms, and partial c-DNA sequence of a precursor. Proc Natl Acad Sci USA 84:5449–53
   PubMed Web of Science ®Google Scholar
• Zesch A. (1983). Skin irritation by topical drugs. Derm Beruf Umwelt 31:74–8
   PubMedGoogle Scholar
• Zhou X, Liu D, Liu H, et al. (2010). Effect of low molecular weight chitosans on drug permeation through mouse skin: 1. Transdermal delivery of baicalin. J Pharm Sci 99:2991–8
   PubMed Web of Science ®Google Scholar
• Zi P, Yang X, Kuang H, et al. (2008). Effect of HPβCD on solubility and transdermal delivery of capsaicin through rat skin. Int J Pharm 358:151–8
   PubMed Web of Science ®Google Scholar